SMAD4 and colorectal carcinoma: It has been reported that the co‐mutation of RAS, SMAD4 and TP53 in metastatic CRC is associated with poor prognosis while the mutation of RAS or TP53 alone is not,61 which reflected the complexity of CRC development.